Overview

A Study to Assess the Safety and Tolerability of Multiple Doses of Multi-Level of a Drug in Subjects With Moderate Asthma

Status:
Completed
Trial end date:
0000-00-00
Target enrollment:
Participant gender:
Summary
This study includes subjects with asthma to participate in one of three groups and randomly assigned to a group to receive the drug for the study (CAT-354) or placebo.
Phase:
Phase 1
Details
Lead Sponsor:
MedImmune LLC